COMPANY · NIPC 500162220

FAES FARMA PORTUGAL, S.A.

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €5,855,335.72 across 859 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameFAES FARMA PORTUGAL, S.A.
NIPC500162220

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2026. The table below gives the same values.2012: €432,563.6220122013: €1,503,673.522014: €1,196,295.2620142015: €353,344.932016: €195,798.0820162017: €114,766.992018: €65,574.7820182019: €126,263.502020: €106,500.6220202021: €161,587.672022: €145,917.4420222023: €174,894.492024: €531,283.4720242025: €659,597.412026: €87,273.942026€1,503,673.52
Contracted value by year
YearContractsContract value
201225€432,563.62
201341€1,503,673.52
201476€1,196,295.26
201551€353,344.93
201642€195,798.08
201730€114,766.99
201836€65,574.78
201942€126,263.50
202034€106,500.62
202168€161,587.67
202246€145,917.44
202354€174,894.49
2024118€531,283.47
2025108€659,597.41
202688€87,273.94
Contracted value by place of performance
NameContractsContract value
Setúbal41€1,268,331.14
Évora10€995,368.52
Faro49€813,663.05
Lisboa142€563,649.61
Coimbra80€512,130.15
Aveiro4€452,482.42
Portalegre11€226,811.16
Portimão13€175,379.01
Elvas12€126,085.38
Barreiro21€116,167.21
Largest contracts
SubjectYearContract value
Medicamentos de consumo geral e outros2013€672,143.38
MEDICAMENTOS EXCLUSIVOS2013€351,447.64
Processo n.o 61/119-Medicamentos para doenças endocrinas2014€164,615.02
Lab. Vitória-Lote 39-300 Sup. de Messalazina 500 mg-36,00 €<br/><br/>Covidien Portugal-Lote 68-100 Apos. Espuma de Poliuretano p/Cav.10x10cm- 92,60 €<br/><br/>B. Braun Medical-Lote 44-1200 Hidroxietilamido 60 mg/ml + Cloreto de sódio 9 mg/m2013€160,234.04
Aquisição de medicamentos exclusivos2014€121,007.23

Who they competed with

In 1,839 contracts with a list of competitors, the company took part and was awarded 160 (9%).

Companies with the most procedures in common
CompanyProcedures in common
generis123
overpharma99
Mylan, Lda.93
Sandoz Farmacêutica, Lda.89
medinfar83
Labesfal-Laboratórios Almiro, S.A79
LOGIFARMA - LOGISTICA FARMACÊUTICA S.A.73
farmoz71
B.Braun Medical, Unipessoal Lda.62
Hikma, SA60
PFIZER49
Pharmakern, Lda.46
Novartis, S.A.45
Fresenius Kabi Pharma Portugal,Lda44
Combino pharm44
tecnifar39
Genéricos - Comércio de Medicamentos S.A.38
Teva Pharma - Produtos Farmacêuticos, Lda.32
Merck, Sharp & Dohme, Lda.29
Prospa, S.A.28
DLA-Farmacêutica,SA.28
organon27
Zentiva, Lda.26
Baxter Médico Farmacêutica, Lda.26
Perrigo Portugal, lda.25
Roche Farmacêutica Química, Lda.24
tecnimede/Farmoz23
orionfin23
Sanofi-Produtos Farmacêuticos,Lda22
Jaba Recordati, S.A22

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents38 companies and 60 links. The list below gives the same content as text.Novartis, S.A. (NIPC 500063524)Novartis, S.A.Sanofi-Produto… (NIPC 500134960)Sanofi-Produto…PFIZER (NIPC 500162166)PFIZERNIPC 500162220 (NIPC 500162220)NIPC 500162220Merck, Sharp &… (NIPC 500191360)Merck, Sharp &…Roche Farmacêu… (NIPC 500233810)Roche Farmacêu…tecnifar (NIPC 500280436)tecnifarmedinfar (NIPC 500384045)medinfartecnimede/Farm… (NIPC 500626413)tecnimede/Farm…Labesfal-Labor… (NIPC 501169580)Labesfal-Labor…farmoz (NIPC 501505334)farmoz+27 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.